A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia

Astellas

Status: Completed

Conditions: Interstitial Pneumonia Associated With Polymyositis/Dermatomyositis

Treatments: Drug: tacrolimus

Study type: Observational

Funder types: Industry

Identifiers

NCT02159651

506-MA-PRGI-01 (Other Identifier)

PRGI01

Details and patient eligibility

About

This study is to evaluate the safety and the efficacy of Prograf in patients with interstitial pneumonia associated with polymyositis / dermatomyositis in acute clinical setting.

Enrollment: 179 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Hospitalized patient
• Patient diagnosed with Interstitial pneumonia associated with polymyositis/dermatomyositis

Trial design

179 participants in 2 patient groups

1: Dermatomyositis group

Description:

patients with interstitial pneumonia associated with dermatomyositis

Treatment:

Drug: tacrolimus

2: Polymyositis group

Description:

patients with interstitial pneumonia associated with polymyositis

Treatment:

Drug: tacrolimus